タイトル | Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds. |
---|
ジャーナル・号・ページ | Proc. Natl. Acad. Sci. U.S.A., Vol. 116, Page 2545-2550, Year 2019 |
---|
掲載日 | 2018年6月1日 (構造データの登録日) |
---|
著者 | Cruz-Migoni, A. / Canning, P. / Quevedo, C.E. / Bataille, C.J.R. / Bery, N. / Miller, A. / Russell, A.J. / Phillips, S.E.V. / Carr, S.B. / Rabbitts, T.H. |
---|
リンク | Proc. Natl. Acad. Sci. U.S.A. / PubMed:30683716 |
---|
手法 | X線回折 |
---|
解像度 | 1.6 - 2.8 Å |
---|
構造データ | PDB-6god: KRAS full length wild-type GPPNHP 手法: X-RAY DIFFRACTION / 解像度: 1.71 Å PDB-6goe: KRAS full length G12V GPPNHP 手法: X-RAY DIFFRACTION / 解像度: 1.6 Å PDB-6gof: KRAS full length G12D GPPNHP 手法: X-RAY DIFFRACTION / 解像度: 1.98 Å PDB-6gog: KRAS-169 Q61H GPPNHP 手法: X-RAY DIFFRACTION / 解像度: 2.05 Å PDB-6gom: KRAS-169 Q61H GPPNHP + PPIN-1 手法: X-RAY DIFFRACTION / 解像度: 1.63 Å PDB-6gqt: KRAS-169 Q61H GPPNHP + PPIN-2 手法: X-RAY DIFFRACTION / 解像度: 1.69 Å PDB-6gqw: KRAS-169 Q61H GPPNHP + CH-1 手法: X-RAY DIFFRACTION / 解像度: 2.8 Å PDB-6gqx: KRAS-169 Q61H GPPNHP + CH-2 手法: X-RAY DIFFRACTION / 解像度: 2.2 Å PDB-6gqy: KRAS-169 Q61H GPPNHP + CH-3 手法: X-RAY DIFFRACTION / 解像度: 2.75 Å |
---|
化合物 | ChemComp-GNP: PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER / Gpp(NH)p / GppNHp, GMPPNP, エネルギー貯蔵分子類似体*YM
ChemComp-F6E: (6~{S})-1-(1~{H}-imidazol-4-ylcarbonyl)-6-[(4-phenylphenyl)methyl]-4-propyl-1,4-diazepan-5-one
ChemComp-F8N: ~{N}-(3-imidazol-1-ylpropyl)-4-[[3-(3-methoxyphenyl)phenyl]methyl]oxane-4-carboxamide
ChemComp-F8T: [4-[[4-(3-methoxyphenyl)phenyl]amino]phenyl]methyl-dimethyl-azanium
ChemComp-F8K: [4-[[2-methoxy-4-(3-methoxyphenyl)phenyl]amino]phenyl]methyl-dimethyl-azanium
ChemComp-F8Q: [4-[[3-fluoranyl-2-methoxy-4-(3-methoxyphenyl)phenyl]amino]phenyl]methyl-dimethyl-azanium
|
---|
由来 | - homo sapiens (ヒト)
|
---|
キーワード | ONCOPROTEIN / KRAS full lenght / KRAS |
---|